Feb 22
|
Why Moderna Inc. (MRNA) Surged On Friday?
|
Feb 21
|
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
|
Feb 20
|
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
|
Feb 19
|
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
|
Feb 19
|
Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
|
Feb 19
|
Why Moderna (MRNA) Went Up on Tuesday?
|
Feb 19
|
Challenges mount for vaccine makers
|
Feb 18
|
Why Moderna (MRNA) Stock Is Up Today
|
Feb 18
|
Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook
|
Feb 18
|
Moderna has limited upside: Barclays
|
Feb 18
|
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?
|
Feb 18
|
Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?
|
Feb 18
|
First Cows, Now Cats. Is Bird Flu Coming for Humans Next?
|
Feb 17
|
Moderna reports decline in Q4 2024 revenue
|
Jan 3
|
Moderna (MRNA) Rises But Trails Market: What Investors Should Know
|
Jan 2
|
Why Moderna Inc. (MRNA) Is Skyrocketing
|
Dec 31
|
S&P 500 Gains and Losses Today: Index Slips as Stocks Close Out Strong Year
|
Dec 31
|
Top Stock Movers Now: Moderna, Verisign, Dave, and More
|
Dec 31
|
This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap.
|
Oct 12
|
2 Biotech Stocks That Are Screaming Buys This Month
|